Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - mycoplasma gallisepticum strain ts-11 - misc. vaccines or anti sera - mycoplasma gallisepticum strain ts-11 vaccine-general active 0.0 ccu/dose - immunotherapy - poultry layers (eggs for human consump) | caged layers | chickens | chooks | hen - chronic respiratory disease | mycoplasma gallisepticum | vaccine | chronic respiratory disease (c | equine rotavirus | infectious sinusitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - newcastle disease strain v-4 virus - misc. vaccines or anti sera - newcastle disease strain v-4 virus vaccine-viral active 0.0 eid 50/d - immunotherapy - poultry broilers (meat for human consum) | chickens | chooks | meat birds - newcastle disease

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - gnrf - protein conjugate; thiomersal - misc. vaccines or anti sera - gnrf - protein conjugate biological-protein active 200.0 ug/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - boar taint

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - mycoplasma synoviae strain ms-h vaccine, living - misc. aural, ophthalmic, oro/naso pharyngeal - mycoplasma synoviae strain ms-h vaccine, living vaccine-general active 105.7 ccu/dose - immunotherapy - poultry broilers (meat for human consum) | poultry layers (eggs for human consump) | poultry pullets (growing chook) | breeding - airsacculitis | chronic respiratory disease | infectious synovitis | vaccine | equine rotavirus | ms

Malta - English - Medicines Authority

mercury pharmaceuticals (ireland) limited 4045 kingswood road, city west business park, co, dublin, ireland - bupivacaine hydrochloride - solution for injection - bupivacaine hydrochloride 2.5 mg/ml - anesthetics

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - bupivacaine hydrochloride - solution for injection - 0.25 percent weight/volume - amides; bupivacaine

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - bupivacaine hydrochloride - solution for injection - 0.5 percent weight/volume - amides; bupivacaine

Malta - English - Medicines Authority

elc group s.r.o. pobrezni 394/12, karlin 186 00 prague 8, czech republic - levodropropizine - syrup - levodropropizine 30 ml/5ml - cough and cold preparations

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - infectious bursal disease virus strain v877 (live) - misc. vaccines or anti sera - infectious bursal disease virus strain v877 (live) vaccine-viral active 0.0 undefined - immunotherapy - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - infectious bursal disease | bursal disease

United States - English - NLM (National Library of Medicine)

huons co., ltd. - bupivacaine hydrochloride (unii: 7tqo7w3vt8) (bupivacaine - unii:y8335394ro) - bupivacaine hydrochloride in dextrose injection, usp is indicated for subarachnoid injection in adults for the production of subarachnoid block (spinal anesthesia). bupivacaine hydrochloride in dextrose injection, usp is contraindicated in: - intravenous regional anesthesia (bier block) [ see warnings and precautions (5.8) ]. - patients with septicemia. - patients with severe hemorrhage, severe hypotension or shock, due to a reduced cardiac output. - patients with clinically significant arrhythmias, such as complete heartblock, due a reduced cardiac output. - patients with a known hypersensitivity to bupivacaine or to any local anesthetic agent of the amide-type or to other components of bupivacaine hydrochloride in dextrose injection, usp. - patients with local infection at the site of proposed lumbar puncture. risk summary the available data on the use of bupivacaine hydrochloride in dextrose injection, usp in pregnant women do not establish the presence or absence of developmental toxicity related